5-α Reductase Inhibitor

7 Drugs classified under this drug class

5-α Reductase Inhibitor. Dutasteride 0.5 mg.
SOFT CAPS.: 30. 1 cap.×1/d.
Tmt.  of moder. - severe sympt. of BPH. To reduce the risk of acute urin. retent. and surgery in pts. with moder.-severe sympt. of BPH.
C/I: Hypersens. to the active ingred./other 5-α-reductase inhib., soya, peanuts. Severe liver dis. Use in women, child. or adolesc.

5-α Reductase Inhibitor. Dutasteride 0.5 mg.
SOFT CAPS: 30. 1 cap. 1 dly.
Mod. to severe sympts. BPH, prevent.
acute urin. retent. and surg. in pts. with
BPH.
C/I: Women and child., known
hypersens., other 5-alpha reductase
inhibitors or any compon. of prep.

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
CAPS: 30. 1 cap orally 30 mins. aft. same
meal each day.
Tmt. mod.-severe sympts. BPH. Reduct.
risk acute urin. retent. (AUR), surg. in pts.
with mod.-severe sympts. BPH.

5-α Reductase Inhibitor. Dutasteride 0.5 mg.
SOFT CAPS.: 10, 30×0.5mg. 1 cap. (0.5 mg) once a day.
Tmt. of moder. –sev. sympt. of BPH.
Reduct. in the risk of acute urinary retent.(AUR) and surg. in pts. with moder.- sev. sympt. of BPH.
C/I: Hypersens.to other 5-alpha-reductase inhib.or to any of drug's excip.
Pts. with severe hepat. dis.
Female pts., child. or adolesc.

5-α Reductase Inhibitor. Finasteride 1 mg.
TABS: 1 mg x 30, 100.
1 mg tablet x 1 dly. May be taken with/
without meals.
Effic., durat. of tmt. should contin. be
assessed by the treat. physic. Gener., 3
or more mths. of once dly. tmt. are
required before evidence of benefit is
observed. Contin. use is recom. to sustain benefit, which should be
re-eval. period.
Tmt. of men with male pattern hair loss
(androgenetic alopecia) to incr. hair
growth and prevent further hair loss.
C/I: Hypersens. to product, not for use in
women and child., not to be used in
comb. with any other med. contain.
Finasteride, Dutasteride, preg.

5-α Reductase Inhibitor. Finasteride 5 mg.
TABS: 28. 1 tab. dly.
BPH.